<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04220697</url>
  </required_header>
  <id_info>
    <org_study_id>POSTOP pain</org_study_id>
    <nct_id>NCT04220697</nct_id>
  </id_info>
  <brief_title>Central Sensitisation and Postoperative Pain</brief_title>
  <official_title>Behavioural and Neurophysiological Measurements for the Assessment of Central Sensitisation and Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      One out of 10 patients undergoing surgery develops persistent post-surgical pain (PPSP).
      Unfortunately, available therapies for treating this pain have limited success. It is
      therefore of great importance to find strategies to prevent PPSP. The goal of this project is
      to find new screening tools that identify patients that are at risk for developing PPSP.

      Tissue injury and inflammation following surgery increase the excitability of spinal
      nociceptive neurons (&quot;central sensitisation&quot;, CS) with pain hypersensitivity as consequence.
      It is thought that CS plays an important role in persistent pain.

      The first objective of this project is to assess in human patients if the propensity to
      develop CS manifested as secondary hyperalgesia before surgery is predictive for PPSP.

      In addition, we will test if the frequency content of the resting-state EEG reflecting the
      initial state of the brain will be related to the propensity for developing CS and to the
      presence of PPSP at two months after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 15, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>mechanical pinprick perceived intensity</measure>
    <time_frame>1 day before surgery</time_frame>
    <description>magnitude of the increase in sensitivity to mechanical pinprick stimuli after HFS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>area of increased mechanical pinprick sensitivity</measure>
    <time_frame>1 day before surgery</time_frame>
    <description>spatial extent of the increased sensitivity to mechanical pinprick stimuli after HFS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>resting state EEG</measure>
    <time_frame>1 week before surgery</time_frame>
    <description>frequency content of the resting state EEG</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Thoracotomy</condition>
  <condition>Hyperalgesia</condition>
  <condition>Hyperalgesia, Secondary</condition>
  <condition>Central Sensitisation</condition>
  <condition>Electroencephalography</condition>
  <condition>Persistent Postsurgical Pain</condition>
  <condition>Humans</condition>
  <arm_group>
    <arm_group_label>patients undergo lateral thoracotomy for primary lung cancer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electroencephalography (EEG) will be acquired before surgery
Questionnaires assessing psychological status of the patients before and after surgery
High frequency electrical stimulation of the skin (HFS) will be delivered before surgery
Quantification of mechanical sensitivity after HFS and after surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>electroencephalography (EEG)</intervention_name>
    <description>recording of resting state EEG using 64 surface electrodes</description>
    <arm_group_label>patients undergo lateral thoracotomy for primary lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>Hospital Anxiety Depression Scale (HADS) Neuropathic Pain questionnaire (DN4) Brief Pain Inventory (BPI) Fatigue Assessment Scale (FAS)</description>
    <arm_group_label>patients undergo lateral thoracotomy for primary lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>high frequency electrical stimulation of the forearm skin (HFS)</intervention_name>
    <description>HFS consists of transcutaneous electrical stimuli delivered as 42 Hz trains (pulse width: 2 ms) lasting 1 s. The trains are repeated 12 times. Each train is separated by 10 seconds.</description>
    <arm_group_label>patients undergo lateral thoracotomy for primary lung cancer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cutaneous mechanical pinprick stimulation</intervention_name>
    <description>Mechanical pinprick stimuli will be applied manually by the operator on the skin using a mechanical stimulator (maximum weight 128 mN).</description>
    <arm_group_label>patients undergo lateral thoracotomy for primary lung cancer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled for a lateral thoracotomy as treatment for primary lung cancer

          -  Ability to provide written informed consent

        Exclusion Criteria:

          -  Evidence for a clinically-significant alteration of the skin of the volar forearms

          -  Pregnancy

          -  Having a pacemaker or implanted cardiac defibrillator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie Lacroix, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emanuel van den Broeke, PhD</last_name>
    <phone>003227645467</phone>
    <email>emanuel.vandenbroeke@uclouvain.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cédric Lenoir, PhD</last_name>
    <phone>003227645467</phone>
    <email>cedric.lenoir@@uclouvain.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Surgery</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Valérie Lacroix, MD, PhD</last_name>
      <phone>003227646107</phone>
      <email>valerie.lacroix@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>January 6, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 7, 2020</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperalgesia</mesh_term>
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

